MG-262 (Z-Leu-Leu-LeuB(OH)2, ZL3B) is a reversible proteasome inhibitor. MG-262 down-regulates VEGF receptor Flt-1. MG-262 inhibits cell growth and induces apoptosis in malignant cells. MG-262 induces reactive oxygen species (ROS). MG-262 can be used for anti-cancer study[1][2][3][4][5].
Molecular Weight:
491.43
Purity:
95
CAS Number:
[179324-22-2]
Formula:
C25H42BN3O6
Target:
Apoptosis,Proteasome,Reactive Oxygen Species (ROS),VEGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted